Inhibiting Cholesterol-associated Protein Reduces High-risk Blockages In Arteries

Saturday, September 27, 2008 - 19:21 in Health & Medicine

Using the drug darapladib, researchers have inhibited a cholesterol-and immune system-associated protein, thereby reducing the development of heart-disease plaques that may cause death, heart attacks, and strokes in a pig model of atherosclerosis and diabetes.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net